BMN-701

5 Things You Need to Know From BioMarin's R&D Day
Motley Fool
Thu, 09/19/13 - 03:09 am
R&D
Biomarin
Vimizim
BMN-701
BMN-111
BMN-673
BioMarin says it will continue studies of late-onset Pompe disease drug candidate BMN-701
Yahoo/AP
Wed, 03/20/13 - 12:26 pm
Biomarin
Pompe disease
BMN-701
Piper Jaffray Boosts Target on BioMarin to $52 After Addition of BMN-701 to Model
Street Insider
Sun, 07/15/12 - 12:02 pm
BMN-701
Biomarin
Pompe disease